Curative Ventures V’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.6M Hold
1,899,004
100% 1
2025
Q4
$20.9M Hold
1,899,004
100% 1
2025
Q3
$33.9M Hold
1,899,004
100% 1
2025
Q2
$39.6M Hold
1,899,004
100% 1
2025
Q1
$33M Hold
1,899,004
100% 1
2024
Q4
$36.3M Hold
1,899,004
100% 1
2024
Q3
$128M Hold
1,899,004
100% 1
2024
Q2
$19.5M Hold
1,899,004
100% 1
2024
Q1
$20.5M Hold
1,899,004
100% 1
2023
Q4
$14.5M Hold
1,899,004
100% 1
2023
Q3
$16.3M Hold
1,899,004
100% 1
2023
Q2
$20.9M Hold
1,899,004
100% 1
2023
Q1
$25.1M Hold
1,899,004
100% 1
2022
Q4
$23.9M Hold
1,899,004
100% 1
2022
Q3
$184M Hold
1,899,004
100% 1
2022
Q2
$175M Hold
1,899,004
100% 1
2022
Q1
$408M Hold
1,899,004
100% 1
2021
Q4
$650M Buy
+1,899,004
New +$733M 100% 1

Other funds holding TIL

Curative Ventures V's TIL Position: Q1 2026 in Review

Curative Ventures V held its Instil Bio (TIL) position steady in Q1 2026 at 1,899,004 shares worth $15.6M. The position accounts for 100% of the portfolio, ranked #1.

Curative Ventures V first reported a position in TIL in Q4 2021 and has held it in 18 quarters since. The position peaked at $650M in Q4 2021. 32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

  • Curative Ventures V held 1,899,004 shares of Instil Bio worth $15.6M as of Q1 2026.
  • Curative Ventures V left its Instil Bio share count unchanged in Q1 2026.
  • Instil Bio made up 100% of Curative Ventures V's portfolio in Q1 2026, its #1 holding.
  • Curative Ventures V first reported a position in Instil Bio in Q4 2021 and has held it in 18 quarters since.
  • Curative Ventures V's Instil Bio position peaked at $650M in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on Curative Ventures V's 13F filing for Q1 2026, filed 29 Apr 2026.